David Feller-Kopman
@dfellerk
Followers
4K
Following
9K
Media
63
Statuses
739
Chief, Pulmonary & Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Pleural and airway enthusiast
Lebanon, NH
Joined June 2011
Worth the read, we have a long way to go: https://t.co/DHLUanbOIn and https://t.co/AC2iwBKq1R
jamanetwork.com
Lung cancer has remained the leading cause of cancer death among men in the US since the early 1950s, among women in the US since 1987, and worldwide for several decades. Lung cancer screening with...
0
2
6
We can't get enough of pleural effusions!! We were so excited to go on @COREIMpodcast to discuss some pearls around pleural effusion diagnosis and management. If you want more, check out our episodes on effusions, empyema, and malignant effusions! https://t.co/3pPzQiUxOf
3
36
130
Lung cancer survival more than doubles from 2000-2020 due to the collective efforts of precision medicine, immunotherapy, & early detection - 5015pts w lung adenocarcinoma🇫🇷 - mOS 8.5m (2000) v 20.7m (2020) @OncoAlert #LCSM
evidence.nejm.org
Lung cancer is the leading cause of cancer-related death worldwide. The aim of the KBP-2020 study was to describe survival among patients diagnosed with lung adenocarcinoma in France in 2000, 2010,...
4
35
134
Development and validation of a diagnostic prediction model for heart failure-related pleural effusions: the BANCA score
0
11
23
Congrats to the Vanderbilt team on getting this done! The bottom line is that in expert hands both robotic-assisted bronchoscopy and electromagnetic navigation have similar diagnostic yields (mid to high 70s) and complication rates.
0
1
8
Charting a Path toward Diagnostic Excellence and Equity in Thoracic Oncology: The Critical Role of Interventional Pulmonologists and Oncopulmonologists @atscommunity
@RogerKimMD
@MPatriciaRivera
@ChrisKapp12 🔓 Open Access 🔗 https://t.co/mSIQxKbALK
0
5
8
That’s a wrap on our 3rd Annual Research Symposium centered around well designed IP clinical trials, advancing AI into our everyday practice, and Advisory Boards to foster partnership. Please reach out if interested in participation! https://t.co/8oi4IdVseF
0
10
19
Come get involved with Interventional Pulmonary research at the 2025 Annual IPOG conference in Baltimore on April 22-23rd. Clinicians, researchers, and industry partners all welcome!!! Agenda: https://t.co/3HpVyUIdzn Registration:
1
4
5
Registration is now open for the 2025 IPOG International Conference! Join us in Baltimore, MD from April 23-24th. Don't miss!!! Register now: https://t.co/EW1zmWtXEZ Agenda: https://t.co/3HpVyUILoV
0
1
3
🚨 Webinar Alert! 🚨 The @atstoa presents: Title: "Advances in Bronchoscopic and Pleural Research Through the Interventional Pulmonary Outcomes Group" 🗓️ Date/Time: Tues, Feb. 4, 2025 | 9 a.m. ET Register Here: https://t.co/4P532LomJ3
1
6
14
ERS statement on benign pleural effusions in adults
1
27
45
Current Trends in Treating Malignant Pleural Effusion: Evidence, Guidelines, and Best Practice Recommendations | JCO Oncology Practice
0
10
17
Those running public health system in next administration may tell you otherwise. Truth is. the #COVID19 vaccination program in the US was a huge success, prevented 3.2 million deaths,18.5 million hospitalizations. Read & circulate. #VaccinesWork
https://t.co/EqSJkLsIdy
commonwealthfund.org
Evidence supports the debate over whether or not vaccines help COVID management and transmission. Discover what ways COVID vaccines have helped.
1
2
11
Interested in academic ILD? Would you like to live where you vacation?
0
1
7
Congrats to first author Chris Gilbert (MUSC) and many others (@dfellerk, @ChristineArgen5, @Bronchking, @Int_Pulmonology, @lonnyyarmus et al) on publication of the @acguidcpchest Guidelines for Acquisition and Handling of EBUS-TBNA samples. https://t.co/TJS7Wu5A7d (1/x)
2
7
17
Excited to share our data on time from #PulmonaryNodule identified to treatment. Take home: 1) Those identifying as black and coming from low-income areas present at Stage IV more commonly 2) Race/Income did not impact timing from diagnosis to treatment https://t.co/YClk280gHJ
4
5
18
1
4
23